Dec
The exclusion of pregnant women from the use of Aurogra underscores a commitment to safety and responsible healthcare. This decision prompts discussions between healthcare providers and women of childbearing age about suitable alternatives and ensures a proactive approach to maternal and fetal health. It reflects a dedication to patient safety and the well-being of both mother and child.